Seeking Alpha

chunk713

chunk713
Send Message
View as an RSS Feed
View chunk713's Comments BY TICKER:
Latest  |  Highest rated
  • Amarin Scrapes The Bottom Of The Barrel [View article]
    You are so right. This author has obviously left this HUGE report last week from NEJM out of his article because this report basically refutes everything the FDA said at the adcom and a few days later for the spa being rescinded. This report make the adcom doctors look VERY bad and really puts the FDA in a bad light! Just why did the FDA do what they did? Well now we know that their conclusions are very wrong thanks to NEJM report. Also remember we could very well get an interim look at reduce-it a lot sooner than anyone thinks and with this NEJM report, reduce-it could be halted for great results!!
    Jun 27, 2014. 08:34 PM | 3 Likes Like |Link to Comment
  • Amarin's Q3 Call Points To Dark Days Ahead [View article]
    Agree homebuilder. I do not know what he was listening to either. Thought the call was very good and strong but hardly signaling "dark days ahead" But this is what I expect from him and people like him. Always trying to keep the hammer on this company.
    Nov 8, 2013. 10:31 AM | Likes Like |Link to Comment
  • Can Amarin Salvage Its Earnings Call? [View article]
    So true. All part of the coordinated bashing of this company for so long. Just showing how ignorant they are. Ignore them!!
    Nov 5, 2013. 09:56 AM | Likes Like |Link to Comment
  • Did The FDA Just Issue Amarin's Death Blow Again? [View article]
    my mistake. Safety was comparable to placebo. Excuse me.
    Oct 31, 2013. 11:15 AM | Likes Like |Link to Comment
  • Did The FDA Just Issue Amarin's Death Blow Again? [View article]
    Big difference. Lovaza is omega 3 with a fair amount of dha in it. Lovaza also has an A-fib warning and raises bad cholesterol as much as 45 percent. Vascepa is pure EPA and their safety and efficacy profile are comparable to placebo. No comparison!!
    Oct 31, 2013. 09:45 AM | 1 Like Like |Link to Comment
  • Did The FDA Just Issue Amarin's Death Blow Again? [View article]
    True. The safety and efficacy of the drug was confirmed during the adcom. Where he came up with this is about as bad as what the FDA has decided to do.
    Oct 30, 2013. 12:06 PM | 3 Likes Like |Link to Comment
  • Analysis of Vascepa's FDA Briefing Documents [View article]
    Hi Steve,
    Great read on whats going on. You and Danburydude seem to have hit the nail on the head. I have one question for you. The end of August you said that Amarin will be releasing a Nuclear bomb in 2 months and towards the end of September you said 1 month to go. Are you able to say what that is? Or will we be finding out on the conference call Wednesday night. Thanks for your article it came at a great time.
    Oct 14, 2013. 08:45 PM | Likes Like |Link to Comment
  • A Stock That May Rally $20 In 3-Months [View instapost]
    Great article Steve. Very well presented and finally puts to rest all the "what if" comments being thrown around by certain sources. I still believe that PFE is the company that will get them and will win the bid. They have much to gain by doing so! Thanks again for writing this article and making clear the FACTS about Amarin and Vascepa!
    Sep 30, 2013. 10:51 AM | 1 Like Like |Link to Comment
  • Yet More New Developmetn Re; Amarin [View instapost]
    Well that is obviously after the ad-com date. Can you give a hint??
    Sep 13, 2013. 06:22 PM | Likes Like |Link to Comment
  • Amarin's Stock Price Movement [View instapost]
    Well said Pirate. The statin combo also will add a great deal to both the market size (roughly double the Anchor market) and the bottom line. Good things coming!!
    Aug 18, 2013. 08:23 PM | Likes Like |Link to Comment
  • Amarin Update After CC [View instapost]
    Pirate - I understand your distrust about the FDA and all the conversation about Anchor being tied to outcomes from Reduce-it, but on the conference call Mr. Ketchum specifically said that there would be No ties for Anchor to outcomes from Reduce-it so that for me puts that to rest for good. I think that a lot of noise was put out there by the hit blogger and his minions that they were hoping to put fear into shareholders. They threw a bunch of non factual comments out and hoped some of it would stick. I listen to the facts as presented and disregard the rest.
    Aug 13, 2013. 02:28 PM | 1 Like Like |Link to Comment
  • Amarin Update After CC [View instapost]
    Danbury- Could not agree more or said it any better. That letter last week from GSK to FDA on the citizens petiton clears the path for Amarin to get NCE. I believe your suspicions about GSK and the hit blogger are right on. The tide is turning for Amarin slowly but surely. Some interesting times are just ahead. Great post!!!
    Aug 11, 2013. 04:02 PM | 2 Likes Like |Link to Comment
  • Amarin Update After CC [View instapost]
    Pirate- I understand your frustration with the stock price where its at. I don't think anyone would say they are happy with it. That being said, I believe the tide is turning for Amarin. You mentioned the short interest being in decline in July but price of stock was down 6 percent. I think the share price drop was due to the delution was it not? I did not expect it to go up at that time. I think a lot of buyers are waiting for the adcom and pdufa for Anchor. I think it is looking very good for approval especially since the 74 day letter came through cleaner than it did in the marine approval. Hence my positive outlook. I also think that a runup to adcom will be likely also.I also understand that nothing is a sure thing and some strange things could happen, ie nce, But the adcom is for safety and efficacy and Vascepa passes both with flying colors. So I am very optimistic about ADCOM and PDUFA being positive. I also think we get NCE also during that period. Then watch the fireworks!!
    Aug 11, 2013. 03:51 PM | 1 Like Like |Link to Comment
  • Amarin Update After CC [View instapost]
    Thanks for pointing that out Steve. Maiwat is a known basher of Amarin so take his posting with a grain of salt. Pirate says he is long the stock but his comments say otherwise since he is very negative. Could be a short in longs clothing? I thought the conference call was very positive especially Mr. Ketchum who is very well versed. Too early in launch to come to any conclusions, after all this was the 1st full quarter of the launch. Its ALL about Anchor now and quite frankly that is looking very good!!
    Aug 10, 2013. 08:19 PM | 2 Likes Like |Link to Comment
  • Yet More New Developmetn Re; Amarin [View instapost]
    Well one point made during the conference call was directed at substantially lowering cost on materials due to BASF and Chemport being approved. I also heard Joe say that " on a conservative estimate that gross profts would be somewhere between 78 to 85 percent". Did everyone miss this?
    Aug 8, 2013. 10:45 PM | Likes Like |Link to Comment
COMMENTS STATS
41 Comments
29 Likes